Immutrin raised $87M Series A venture round, led by Frazier Life Sciences.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Private |
| — |
| Venture Capital | — |
James TopperLEAD | Angel | James Topper |
| Private | — |
| University Fund | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$87M
Top Valuation
-
Immutrin raised $87M in a Series A round.
The round was announced on 03/01/26.
The round was led by Frazier Life Sciences, James Topper, James Topper.